Trabectedin tactics: from sea squirts to sarcomas

被引：0

作者：

Randall, R. Lor ^{[1
]}

Cable, Matthew G. ^{[1
]}

机构：

[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

来源：

LANCET ONCOLOGY | 2015年 / 16卷 / 03期

关键词：

ANTITUMOR-ACTIVITY; ECTEINASCIDIN-743;

D O I：

10.1016/S1470-2045(15)70062-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：243 / 244

页数：3

共 9 条

[1] Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas [J].

Blay, Jean-Yves ;

Leahy, Michael G. ;

Binh Bui Nguyen ;

Patel, Shreyaskumar R. ;

Hohenberger, Peter ;

Santoro, Armando ;

Staddon, Arthur P. ;

Penel, Nicolas ;

Piperno-Neumann, Sophie ;

Hendifar, Andrew ;

Lardelli, Pilar ;

Nieto, Antonio ;

Alfaro, Vicente ;

Chawla, Sant P. .

EUROPEAN JOURNAL OF CANCER, 2014, 50 (06) :1137-1147

[2] Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials [J].

Cesne, A. L. ;

Judson, I. ;

Maki, R. ;

Grosso, F. ;

Schuetze, S. ;

Mehren, M. V. ;

Chawla, S. P. ;

Demetri, G. D. ;

Nieto, A. ;

Tanovic, A. ;

Blay, J-Y .

BRITISH JOURNAL OF CANCER, 2013, 109 (07) :1717-1724

[3] Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity [J].

Delaloge, S ;

Yovine, A ;

Taamma, A ;

Riofrio, M ;

Brain, E ;

Raymond, E ;

Cottu, P ;

Goldwasser, F ;

Jimeno, J ;

Misset, JL ;

Marty, M ;

Cvitkovic, E .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1248-1255

[4] Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study [J].

Grosso, Federica ;

Jones, Robin L. ;

Demetri, George D. ;

Judson, Ian R. ;

Blay, Jean-Yves ;

Le Cesne, Axel ;

Sanfilippo, Roberta ;

Casieri, Paola ;

Collini, Paola ;

Dileo, Palma ;

Spreafico, Carlo ;

Stacchiotti, Silvia ;

Tamborini, Elena ;

Tercero, Juan Carlos ;

Jimeno, Jose ;

D'Incalci, Maurizio ;

Gronchi, Alessandro ;

Fletcher, Jonathan A. ;

Pilotti, Silvana ;

Casali, Paola G. .

LANCET ONCOLOGY, 2007, 8 (07) :595-602

[5] In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients [J].

Izbicka, E ;

Lawrence, R ;

Raymond, E ;

Eckhardt, G ;

Faircloth, G ;

Jimeno, J ;

Clark, G ;

Von Hoff, DD .

ANNALS OF ONCOLOGY, 1998, 9 (09) :981-987

[6] Progress in the clinical development of new marine-derived anticancer compounds [J].

Jimeno, J ;

López-Martín, JA ;

Ruiz-Casado, A ;

Izquierdo, MA ;

Scheuer, PJ ;

Rinehart, K .

ANTI-CANCER DRUGS, 2004, 15 (04) :321-329

[7] Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial [J].

Le Cesne, Axel ;

Blay, Jean-Yves ;

Domont, Julien ;

Tresch-Bruneel, Emmanuelle ;

Chevreau, Christine ;

Bertucci, Francois ;

Delcambre, Corinne ;

Saada-Bouzid, Esma ;

Piperno-Neumann, Sophie ;

Bay, Jacques-Olivier ;

Mir, Olivier ;

Ray-Coquard, Isabelle ;

Ryckewaert, Thomas ;

Valentin, Thibaud ;

Isambert, Nicolas ;

Italiano, Antoine ;

Clisant, Stephanie ;

Penel, Nicolas .

LANCET ONCOLOGY, 2015, 16 (03) :312-319

[8] A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations [J].

Leporini, Christian ;

Patane, Marinella ;

Saullo, Francesca ;

Rende, Pierandrea ;

Gallelli, Luca ;

Di Paola, Eugenio Donato ;

Toscano, Rosa ;

Lucia, Maria ;

Rossi, Marco ;

De Sarro, Giovambattista ;

Russo, Emilio .

BIODRUGS, 2014, 28 (06) :499-511

[9]

Valoti G, 1998, CLIN CANCER RES, V4, P1977

← 1 →